Actually, that's a perfect example. Gilead offers a cure (well, now, two) for Hepatitis C, yet there is an uproar about the cost (US$60,000 and up). So, they

Actually, that's a perfect example. Gilead offers a cure (well, now, two) for Hepatitis C, yet there is an uproar about the cost (US$60,000 and up). So, they are under a lot of pressure to drop the price severely and already charge much less outside the U.S. Now, contrast if they had made it a chronic treatment, needing dosing forever, and charged US$10K-15K/year. The media would have hardly bat an eyelash at that cost... and Gilead would have have made more money in the long run.